Health Catalyst (HCAT) CPO uses 8,519 shares in mandated tax sell-to-cover

Rhea-AI Filing Summary

Health Catalyst, Inc. Chief People Officer Linda Llewelyn reported a routine share disposition tied to taxes on vested equity. On the transaction date, 8,519 shares of common stock were used in a mandated "sell to cover" transaction at an average price of $1.3702 per share to satisfy tax withholding obligations from vested restricted stock units. This was required under the company’s equity incentive plans and is described as a non-discretionary transaction rather than an open-market sale. After this event, Llewelyn directly held 321,132 shares of Health Catalyst common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Llewelyn Linda

Role Chief People Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	8,519	$1.3702	$12K

Holdings After Transaction: Common Stock — 321,132 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withholding shares: 8,519 shares Average price per share: $1.3702 per share Post-transaction holdings: 321,132 shares +1 more

4 metrics

Tax-withholding shares 8,519 shares Shares used in sell-to-cover transaction

Average price per share $1.3702 per share Price for tax-withholding disposition

Post-transaction holdings 321,132 shares Directly held after transaction

Tax-withholding transactions 1 transaction, 8,519 shares Summary of F-code activity

Key Terms

Restricted Stock Units, sell to cover, equity incentive plans, tax withholding obligations, +1 more

5 terms

Restricted Stock Units financial

"in connection with the vesting of Issuer's Restricted Stock Units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sell to cover financial

"to be funded by a "sell to cover" transaction and does not represent"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

equity incentive plans financial

"mandated by the Issuer's election under its equity incentive plans to require"

Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.

tax withholding obligations financial

"to cover tax withholding obligations in connection with the vesting"

Form 4 regulatory

"Health Catalyst, Inc. Chief People Officer Linda Llewelyn reported a routine share disposition"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Llewelyn Linda

(Last) (First) (Middle)

C/O HEALTH CATALYST, INC.

10897 SOUTH RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		F		8,519(1)	D	$1.3702	321,132	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

	/s/Benjamin Landry, as Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Health Catalyst (HCAT) report for Linda Llewelyn?

Health Catalyst reported that Chief People Officer Linda Llewelyn used 8,519 common shares to cover tax withholding on vested restricted stock units. The transaction was recorded as a mandatory sell-to-cover event under the company’s equity incentive plans, not a discretionary market trade.

How many Health Catalyst (HCAT) shares were used to cover taxes in this Form 4?

The Form 4 shows 8,519 Health Catalyst common shares were disposed of at an average price of $1.3702 per share. These shares were required to be sold to satisfy tax withholding obligations triggered by the vesting of restricted stock units awarded to the executive.

Was Linda Llewelyn’s Health Catalyst (HCAT) transaction an open-market sale?

No, the filing states the shares were sold solely to cover tax withholding obligations from restricted stock unit vesting. The company’s equity incentive plans mandated a sell-to-cover structure, and the filing notes this does not represent a discretionary trade by the reporting person.

How many Health Catalyst (HCAT) shares does Linda Llewelyn hold after this transaction?

Following the tax-related disposition of 8,519 shares, Linda Llewelyn directly holds 321,132 shares of Health Catalyst common stock. This post-transaction balance is disclosed in the Form 4 and reflects her remaining equity position after the mandated sell-to-cover event.

What does the F transaction code mean in Health Catalyst (HCAT) insider filings?

In this Form 4, the F code indicates a tax-withholding disposition, where shares are delivered to satisfy tax obligations or exercise price. The filing explains the company required a sell-to-cover transaction for restricted stock unit vesting, rather than an elective market sale by the insider.